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1. Introduction
  In recent years, the incidence of ischemic cerebrovascular 
disease has increased year by year and become one 
important disease which is a threat to human health now. 
The local cerebral blood supply reduced or completely 
interrupted and can not be restored in time, the loss of 
blood supply leads to the short supply of oxygen and 
glucose and cause the death of that area of brain tissue 
then results in cerebral infarction[1]. Cerebral ischemia 
damage process including inflammation, apoptosis and a 
series of complex pathological reactions, and Akt/HIF-1
毩 signal transduction pathways plays an important role in 
cell proliferation, growth, differentiation and apoptosis[2]. 
Research shows that in addition to anti-inflammatory, anti-
apoptotic, anti-oxidation effects, silybin can also play a 
role of cerebral protection in ischemic brain injury[3]. In this 
study, we established the rat model of cerebral ischemia 
which induced by permanent middle cerebral artery 
Objective: To explore the neuroprotective effect of pAkt and HIF-1毩 on ischemia rats. 
Methods: The rat model of cerebral ischemia which induced by permanent middle cerebral 
artery occlusion was established, Silybin were given respectively. The behavior was measured 
by modified Longa method, brain water content were measured by the dry-wet method. Infarct 
volume was measured by image analysis method, Akt, HIF-1毩, Bcl-2, Bax, NF-毷B protein 
expressions were detected by Western blotting. The Akt, HIF-1毩, Bcl-2, Bax, NF-毷B mRNA 
expression were detected by RT-PCR. Results: The control group, low-dose silibinin group 
and high-dose silibinin group showed paralytic of the left body of rats in various degrees, 
the brain water content increased and different infarction size. There was no abnormal of the 
neurobehavioral assessment and no cerebral infarction in the blank group. Compared with the 
control group, there was no significant improvement of neurological function (t=1.341, P=0.188) 
or significant changes of the infarct volume (t =1.737, P=0.091) in the low-dose silibinin group, 
while there was significantly improvement of the neurological function in the high dose silibinin 
group (t=12.979, P<0.001), and the infarct volume was significantly reduced (t=23.503, P<0.001), 
the difference had statistically significant. The brain water content of lesion side of the control 
group increased (t= 43.536, P<0.001), while the brain water content of lesion side of the low-
dose silibinin group and the high-dose silybin group were significantly reduced (t=25.571, 
P<0.001; t= 42.426, P<0.001). The differences were statistical significance. The p-Akt 473, 
p-Akt 308, HIF-1毩, Bax, NF-毷B protein and the Akt, Bax, NF-毷B mRNA expression were 
increased of the control group, while the Bcl-2 protein and mRNA expression were decreased, 
the differences were statistically significant (P<0.05), there was no significant change of the Akt 
protein expression and HIF-1毩 mRNA in the control group (P>0.05). In the high dose silybin 
group, the p-Akt 473, p-Akt 308, HIF-1毩, Bcl-2 protein and Akt, Bcl-2 mRNA expression were 
increased, while the Bax, NF-毷B protein and Bax, NF-毷B mRNA expression were decreased, 
the differences were statistically significant (P<0.05), there was no significant change of the Akt 
protein expression and HIF-1毩 mRNA in the high dose silybin group (P>0.05). Conclusions: 
pAkt, HIF-1毩 have neuroprotective effect on ischemia rats.
Bao-Nan Liu et al./Asian Pacific Journal of Tropical Medicine (2014)221-225222
occlusion and observed the Akt, HIF-1毩, Bcl-2, Bax, NF-
毷B expression after administration of silybin, explore the 
neuroprotective effect of pAkt and HIF-1毩 on ischemia rats 
and further study the possible mechanism.
2. Materials and methods
2.1. Materials
  Silybin (Nanjing Zelang Medical Technology Co., Ltd.) as a 
neuroprotective drugs. 2,3,5-Triphenyltetrazolium chloride 
(Sigma, USA) as a coloring agent, Western blot reagent 
(Sigma, USA), RT-PCR Reagents (U.S. Promega Corporation).
2.2. Method
2.2.1. Experimental animals and grouping
  Totally 80 male healthy adult Sprague-Dawley mice of 
clean grade were selected, average weighted (265.3依15.4) g.
They were provided by the Experimental Animal Center of 
our Medical University, and were fed with standard diet and 
purified water. Rearing temperature was at 20-25 ℃. The 
rats were randomly divided into four groups (n= 200): blank 
group, control group, low-dose silybin group and high-dose 
silybin group. The behavioral assessments were performed 
72 h after surgery for rats in each group. The animals 
were decapitated and the brain water content (BWC) were 
measured by the dry-wet method, stained with TTC then 
measured the infarct volume. Finally, the Akt, HIF-1毩,
Bcl-2, Bax, NF-毷B expression were detected by Western 
blotting and RT-PCR.
2.2.2. Establish animal models
  Middle cerebral artery occlusion were established with 
modified Longa method in the right side of rats[4].
2.2.3. Methods of administration
  All drugs were administered by intragastric administration. 
Low-dose silybin group: 75 mg/kg silybin solution per rat 
daily, high-dose silybin group: 150 mg/kg silybin solution 
per rat daily, blank group and the control group received 
equivalent normal saline.
2.3. Evaluation
  The praxiology evaluation was measured by modified Longa 
method[5]. 5 points: fall down when walking to the opposite 
side; 4 points: severe circling to the contralateral; 3 points: 
mild circling to contralateral; 2 points: contralateral forelimb 
flexion; 1 point: contralateral forelimb can not fully extend; 
0: no neurological damage.
  BWC were measured by the dry-wet method. The size of 
brain tissue infarct of every piece, the size on infarct side 
and contralateral were obtained by Image-Pro Plus5.1.
  Akt, p-Akt 473, p-Akt 308, HIF-1毩, Bcl-2, Bax, NF-毷
B protein expression were detected by Western blotting. 
Akt, HIF-1毩, Bcl-2, Bax, NF-毷B mRNA expression were 
detected by RT-PCR. 
2.4. Statistical analysis
  All data involved in this study were analyzed with SPSS 
software. Neurobehavioral assessment, brain tissue water 
content, infarct volume, Western blotting, RT-PCR results 
were analyzed by ANOVA and SNK-q test, P<0.05 was 
regarded as statistically significant.
3. Results
3.1. Neurobehavioral assessment, BWC and infarct volume.
  The control group, low-dose silibinin group and high- 
dose silibinin group showed paralytic of the left body of 
rats in various degrees and different infarction size. There 
was no abnormal of the neurobehavioral assessment and 
no cerebral infarction in the blank group. Compared with 
the blank group, the BWC of lesion side of the control 
group increased, the difference was statistically significant 
(t=43.536, P<0.001). Compared with the control group, there 
was no significant improvement of neurological function 
(t=1.341, P=0.188) or significant changes of the infarct 
volume (t=1.737, P= 0.091) in the low-dose silibinin group, 
while the BWC of lesion side was significantly reduced, the 
difference had statistically significant (t=25.571, P<0.001). 
There was significantly improvement of the neurological 
function in the high dose silibinin group, BWC of lesion 
side was significantly reduced and the infarct volume was 
significantly reduced (t=12.979, P<0.001; t=42.426, P<0.001; 
t=23.503, P<0.001), the difference had statistically significant 
(Table 1).
3.2. Akt, p-Akt 473, p-Akt 308, HIF-1毩, Bcl-2, Bax, NF-
毷B protein expression
  Compared with the blank group, p-Akt 473, p-Akt 308, 
HIF-1毩, Bax, NF-毷B protein were increased of the control 
group after 72 hours of cerebral ischemia, while the Bcl-2 
protein expression were decreased, the differences were 
statistically significant (P<0.05), there was no significant 
change of the Akt protein expression and HIF-1毩mRNA in 
the control group (P>0.05). 
  Compared with the control group, p-Akt 473, p-Akt 308, 
HIF-1毩, Bcl-2 protein and Akt, Bcl-2 mRNA expression 
of the high dose silybin group were increased, while the 
Bax, NF-毷B protein and Bax, NF-毷B mRNA expression 
were decreased, the differences were statistically significant 
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(P<0.05), there was no significant change of the Akt protein 
expression and HIF-1毩 mRNA in the high dose silybin 
group (P> 0.05) (Figure 1).
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Figure 1. Protein expression results of the rats 72 hours postoperative.
Compared with the blank group, *P<0.05; compared with control 
group, # P<0.05.
3.3. Akt, HIF-1毩 , Bcl-2, Bax, NF-毷B mRNA expression
  Compared with the blank group, Akt, Bax, NF-毷B mRNA 
expression were increased of the control group after 72 hours 
of cerebral ischemia, while the Bcl-2 mRNA expression 
were decreased, the differences were statistically significant 
(P<0.05), there was no significant change of the HIF-1毩 
mRNA expression in the control group (P>0.05). 
  Compared with the control group, Akt, Bcl-2 mRNA 
expression of the high dose silybin group were increased, 
while the Bax, NF-毷B mRNA expression were decreased, 
the differences were statistically significant (P<0.05), there 
was no significant change of the HIF-1毩mRNA  expression 
in the high dose silybin group (P>0.05) (Figure 2, 3).
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Figure 2. mRNA expression results of the rats 72 hours postoperative.
Compared with the blank group, *P<0.05; compared with control 
group, # P<0.05.
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Figure 3. mRNA expression.
A: Akt mRNA expression; B: HIF-1毩 mRNA expression; C: Bcl-2 
mRNA expression; D: Bax mRNA expression; E:  NF-毷B mRNA 
expression.
4. Discussion
  Ischemic cerebrovascular disease has a high disability rate 
and death rate, and has become one of the significant threats 
to human health and life. The disorder of circulatory system 
is an important reason for its formation. Establishment of 
the cerebral ischemia rat model is the key to study the 
neuroprotective effects of experimental rats. The middle 
cerebral artery occlusion model of rats has been universally 
accepted, which is a standard model to establish focal 
cerebral ischemia. The model can have cytotoxic effects 
in a few minutes, such as inflammation, apoptosis, nerve 
injury[7]. The experimental animal model was established 
strictly in accordance with the modified Longa, and to 
explore the the neuroprotective effect of pAkt and HIF-1毩 
on ischemia rats based on this model.
  Silybin is a flavonolignan compound which can be 
Table 1. 
Neurobehavioral scores, BWC, infarct volume results of rats 72 hours postoperative(mean依SD).
Groups n Neurobehavioral score (points) BWC (%) Infarct volume (%)
Blank group 20  0.00依0.00 78.01依0.77   0.00依0.00
Control group 20  4.08依0.28  87.11依0.53* 47.50依2.45
Low dose silibinin group 20  3.96依0.29  82.27依0.66# 46.11依2.61
High dose silibinin group 20   2.78依0.35#  78.01依0.77#   30.23依2.19#
Note: Compared with the blank group, * P<0.001; compared with control group, # P<0.001.
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extracted from the medicinal plants of compositae. It has 
been proved that silibinin has anti-inflammatory, anti-
apoptotic, anti-oxidation and other biological functions, 
Ryou et al[8] also found it has the anti-cancer and anti-
cancer effect.In this study. The neurological function have 
been significantly improved of rats in the high dose group, 
and the BWC decreased to (78.32%依0.76%), infarct volume 
decreased by 36.4% compared with the control group. That 
suggested silibinin has a good neuroprotective effect on 
early ischemia, which may because silibinin can inhibit the 
NF-毷B and signal transduction, transcriptional activators 
and expression and activation[9].
  Akt is a Ser / Thr protein kinase,the necessary prerequisite 
of Akt to play a catalytic role in cell survival is the 
phosphorylation of Ser473 sites and/or Thr308 sites, that 
is, the formation of p-Akt 473, p-Akt 308. Akt activation 
depends on phosphoinositide-dependent protein kinase 
synergies and the translocation from the cytoplasm to the 
plasma membrane[10]. In this experiment, compared with the 
blank group, after 72 hours of cerebral ischemia of rats in 
the control group, p-Akt 473, p-Akt 308 protein expression 
was significantly increased, in which p-Akt 473 increased 
by 76.7%, p-Akt 308 increase by 57.6%. Compared with the 
control group, the neurological function had a significant 
improvement of the silibinin high dose group, in which the 
p-Akt 473, p-Akt 308 protein expression increased more 
significantly, the expression is almost 2 times of the control 
group. This shows that the p-Akt 473, p-Akt 308 proteins 
play a protective role in the nervous system in experimental 
ischemia rat. Studies have shown that the activation of Akt 
is mainly through the promotion of the phosphorylation of 
downstream molecules such as the Bcl-2 apoptosis related 
family members, NF-毷B, mammalian target of rapamycin( 
mTOR), glycogen synthase kinase -3 to anti-apoptosis and 
promote cell survival[11].
  mTOR is phosphoinosititide kinase-related kinase family 
member, is also a Ser / Thr protein kinase, exist in the 
cytoplasm[12]. Study found that the mechanism of mTOR 
activity regulation and control is very complex, and is 
related with a variety of signaling proteins regulation. In 
which the most important two signal transduction pathway 
were PI3K/Akt/mTOR signaling pathway and LKBI/AMPK/
mTOR signaling pathway[13]. Sato et al[14] reported that Akt/
mTOR is  closely related to HIF-1毩.Akt/mTOR’s expression 
on HIF-1毩 and activity regulation can be carried out in 
normoxic and hypoxic conditions. The detection of HIF-1
毩 in this experiment showed that compared with the blank 
group, the expression of HIF-1毩 was significantly increased 
in the control group, especially in rats which nerve function 
have improved significantly, and positively correlated with 
pAkt expression, which indicating that the Akt/mTOR/HIF-1
毩 neural pathway has the neuroprotective effect of pAkt 
and HIF-1毩 on ischemia rats. Therefore, the role of Akt/
mTOR/HIF-1毩 neural pathway in ischemic brain disease 
has been very popular and become research hotspot.
  HIF-1毩 is a member of hypoxia inducible factor gene 
family.Its important feature is that can be only detected 
in the hypoxic environment.Its structure is divided into 
N-terminal domain and C-terminal domain[15]. Studies 
have shown that[16] C-TAD section has transcriptional gene 
activity. In ischemic hypoxia environment, HIF-1毩 plays 
a key role in regulating acute and chronic physiological 
adaptation to brain tissue hypoxia. The mechanism may 
because HIF-1毩 can regulate those gens which have the 
potential to protect and restore the role of neural genes, such 
as vasomotor control genes and erythropoietin genes[17], 
so that the body can adapt to hypoxia ischemia. Taking 
erythropoietin gene for example, the increasing of HIF-1毩 
expression will generate more hormone erythropoietin, which 
can promote a large number of red blood cell production into 
the blood, enhanced the blood vessel’s ability to transport 
oxygen. At the same time the increase content of hemoglobin 
can enhance the oxygen transport capacity, thus can reduce 
the damage of brain tissue.
  In this study, we also detected the Bcl-2, Bax, NF-毷B 
protein and mRNA expression of the experimental ischemia 
rats. Compared with the blank group, after 72 hours of the 
ischemic injury of rats in the control group, Bcl-2 protein 
and mRNA expression were significantly decreased, while 
the NF-毷B, Bax protein and mRNA expression were 
significantly increased, the differences were statistically 
significant (P<0.05). NF-毷B inducing and activation in the 
case of cerebral ischemia, its signaling pathway in brain 
tissue cause neuronal death has become a research hotspot 
of ischemic animal experiments and clinical research at 
home and abroad[18,19]. Bcl-2, Bax are the most important 
genes in the regulation and control of ischemic neuronal 
apoptosis in rats, in which the Bcl-2 inhibits neuronal 
apoptosis while the Bcl-2 expression is positively correlated 
to the apoptosis of nerve sensitivity. Bax belongs to genes 
which can promote neuronal apoptosis and is a member 
of the Bcl-2 gene family[20]. Therefore, Bcl-2 expression 
increasing can reduce neuronal apoptosis, in contrast, Bax 
expression increasing can cause more neurons apoptosis. 
Consistent with this experimental results, p-Akt have the 
neuroprotective effect on ischemia rats by regulating Bcl-2, 
Bax.
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